Ads
related to: moderna vaccine
Search results
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 56 minutes agoThe vaccine, a critical component of Moderna’s pipeline, has bolstered investor confidence following...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 3 hours agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 3 hours agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 4 hours ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
Moderna Investors Just Got Some Bullish News | The Motley Fool
The Motley Fool· 7 hours agoModerna (MRNA 3.91%) jumped into the limelight when it started developing a coronavirus vaccine...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 8 hours agoIn 2023, Moderna agreed to establish an mRNA manufacturing facility in Kenya. The new advanced facility will have the capacity to produce up to 500...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 5 hours agoThe revision follows the approval of Moderna's Respiratory Syncytial Virus (RSV) vaccine by...
Is Moderna Stock a Buy Now That It's a 2-Product Company? | The Motley Fool
The Motley Fool· 6 hours agoThe shortened trading week that ended on May 31 was a strange one for the vaccine developer Moderna...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 3 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 4 hours agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...